ACTRAPID

This brand name is authorized in Australia, Austria, Croatia, Cyprus, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Israel, Lithuania, Netherlands, New Zealand, Nigeria, Poland, Romania, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug ACTRAPID contains one active pharmaceutical ingredient (API):

1	Insulin human biosynthetic UNII 1Y17CTI5SR - INSULIN HUMAN
	The blood glucose lowering effect of insulin is due to the facilitated uptake of glucose following binding of insulin to receptors on muscle and fat cells and to the simultaneous inhibition of glucose output from the liver.
	Read more about Insulin (human)

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ACTRAPID Solution for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10AB01	Insulin (human)	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AB Insulins and analogues for injection, fast-acting
Discover more medicines within A10AB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	1531N, 1762R
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00145589, 00145603, 00536338, 00536427, 00536692, 00536700, 00536752, 00536775, 02949004, 03029665, 03366279, 03647328, 03647334, 03743173, 03743210, 04091399, 04091407, 04245916, 04245922, 04393692, 04393717, 04405780, 04405797, 06135913, 06306958, 07653283, 10739663, 13711808, 14218524, 15861357, 16582056
EE	Ravimiamet	1006355, 1011463, 1215740, 1215751, 1215773, 1215784, 1215795, 1215807, 1215818, 1318137, 1318148, 1318159, 1318160
ES	Centro de información online de medicamentos de la AEMPS	02230003, 02230011
FI	Lääkealan turvallisuus- ja kehittämiskeskus	013509
FR	Base de données publique des médicaments	61995884, 62809126
GB	Medicines & Healthcare Products Regulatory Agency	33122
HK	Department of Health Drug Office	25781, 60290, 63758, 66078
IE	Health Products Regulatory Authority	62006
IL	מִשְׂרַד הַבְּרִיאוּת	2862, 646
LT	Valstybinė vaistų kontrolės tarnyba	1004376, 1008808, 1015618, 1015622, 1027228, 1027229, 1027231, 1027232, 1027233, 1027234, 1027235, 1027236, 1027237, 1027238, 1027239, 1027240, 1027241
NG	Registered Drug Product Database	A6-0449
Switch country to Nigeria in order to find specific presentations of ACTRAPID
NL	Z-Index G-Standaard	14816032, 14816040, 14816059
NL	Z-Index G-Standaard, PRK	97314, 97322, 97330
NZ	Medicines and Medical Devices Safety Authority	10728, 3501, 3519
PL	Rejestru Produktów Leczniczych	100031049, 100103180, 100308485, 100308491, 100308500
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W03621002, W03621003, W10503001, W10503002, W10503003, W13933001, W13933002, W13933003, W52539001, W52539002, W52539003, W52540001, W52540002, W52540003, W52541001, W52541002, W52541003
SG	Health Sciences Authority	02395P, 02397P
TN	Direction de la Pharmacie et du Médicament	5993016, 5993024
TR	İlaç ve Tıbbi Cihaz Kurumu	8699676770496, 8699676950348
ZA	Health Products Regulatory Authority	W/21.1/288